David P Warshal MD

Obstetrics & Gynecology•Camden, NJ

Gynecologic Oncology

Associate Professor, Obstetrics and Gynecology, Cooper Medical School of Rowan Univ

Join to View Full Profile

2 Cooper Plaza 400 Haddon AveCamden, NJ 08103
Phone+1 855-632-2667

Education & Training

University of Rochester Medical CenterFellowship, Gynecologic Oncology, 1992 - 1994
University of Rochester Medical CenterResidency, Obstetrics and Gynecology, 1987 - 1991
Nassau University Medical CenterInternship, Internal Medicine, 1986 - 1987
Pennsylvania State University College of MedicineClass of 1986

Certifications & Licensure

PA State Medical License 1991 - 2026
NJ State Medical License 1997 - 2025
NY State Medical License 1988 - 1994
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Inside Jersey Top Doctors for Cancer Castle Connolly, 2012-2014
Inside Jersey Magazine Top Doctors Castle Connolly, 2010-2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Inside Jersey - Top Doctors for Women's Health Castle Connolly, 2010-2012
Philadelphia Magazine Castle Connolly, 2009-2012
Most Compassionate Doctor American Registry
Top MD Consumers Checkbook
Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Join now to see all

Clinical Trials

Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
Active, not recruiting
Phase 2
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
ACTIVE_NOT_RECRUITING
PHASE3
Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Dec 13
Completed
Phase 2
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2012 Jan 09
Completed
Phase 3
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery Start of enrollment: 2012 Jun 04
Terminated
Phase 3
Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva Start of enrollment: 2012 Jul 02
Active, not recruiting
Phase 2
Psychological Interventions for Gynecologic Cancer Start of enrollment: 2010 Jun 01
Completed
Not Applicable
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Start of enrollment: 2014 Mar 17
Active, not recruiting
Phase 2, Phase 3
Study with Afuresertib and Paclitaxel in Platinum Resistant Ovarian Start of enrollment: 2020 Jun 09
COMPLETED
PHASE2
Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer Start of enrollment: 2015 Sep 23
ACTIVE_NOT_RECRUITING
PHASE2
Roles: Contact, Principal Investigator
Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer Start of enrollment: 2022 Sep 28
ACTIVE_NOT_RECRUITING
PHASE2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

1 citations
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma.
Daniela E Matei, Danielle M Enserro, Marcus E Randall, David Mutch, William Small
Journal of Clinical Oncology. 2025-03-20
Evaluation of physical function and quality of life before and after nonradical surgical therapy for stage IA1 and IA2-IB1 cervical cancer (GOG-0278).
Jeanne Carter, Helen Q Huang, Bradley J Monk, Yong-Beom Kim, Moon-Hong Kim
Gynecologic Oncology. 2025-03-08
Evaluation of efficacy and fertility after nonradical surgical therapy (extra fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1, IA2, and...
Allan Covens, Helen Q Huang, Bradley J Monk, Yong-Beom Kim, Moon-Hong Kim
Gynecologic Oncology. 2025-03-07

Press Mentions

Cooper Foundation Receives Another Major Donation for Ovarian Cancer ResearchAugust 22nd, 2024
Top Physicians 2018February 27th, 2019

Professional Memberships

American Society of Clinical Oncology - ASCO
Member